Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 Oct 20;13:1058178. doi: 10.3389/fphar.2022.1058178

Erratum: Case report: PTEN mutation induced by anti-PD-1 therapy in stage IV lung adenocarcinoma

Frontiers Production Office*
PMCID: PMC9632993  PMID: 36339554

Due to a production error, the author affiliations were listed incorrectly, as “Junjie Teng1,2,†, Kai Zhou2,†, Dongxiao Lv2, Changshun Wu3,* and Hong Feng2,*” instead of “Junjie Teng1,2,†, Kai Zhou1,†, Dongxiao Lv1, Changshun Wu3,* and Hong Feng1,*”.

The publisher apologizes for this mistake. The original version of this article has been updated.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES